My Progress Program Title Credit Type Therapeutic Area Format
Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
Novel Therapeutic Strategies for the Treatment of Triple-Negative Breast Cancer
CME
,
CNE
,
AANP
,
CPE
,
Participation
,
AAPA
Oncology On-Demand Webcast
Pharmacy Perspectives in CLL/SLL: Navigating a Rapidly Evolving Treatment Landscape
CPE
,
Participation
Hematology, Oncology On-Demand Webcast
Novel Medications for the Treatment of NHL: A Closer Look at Anti-CD30 Antibodies, EZH2 Inhibitors, and PI3K Inhibitors
CPE
,
Participation
Hematology, Oncology On-Demand Webcast
Emerging Treatment Regimens in MCL: Pharmacy-Based Management Strategies
CPE
,
Participation
Hematology, Oncology On-Demand Webcast
Addressing Pharmacy Challenges in Multiple Myeloma: Strategies for Overcoming Treatment Resistance
CPE
,
Participation
Hematology, Oncology On-Demand Webcast